RIVAROXABAN | N215859 | JANSSEN PHARMACEUTICALS INC
61 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Mar 27, 2026 | SUPPL -7 | View Letter (PDF) |
| Jun 18, 2025 | SUPPL -5 | View Letter (PDF) |
| Feb 9, 2023 | SUPPL -2 | View Letter (PDF) |
| May 19, 2022 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.